Impact of p53 and Ki-67 in predicting recurrence and progression of superficial (pTa and pT1) urothelial cell carcinomas of urinary bladder

Pathology International

Volumn 52, Issue 7, 2002, Pages 463-469

  Kilicli Camur, Nurcan ^a   Kilicaslan, Isin ^a,b   Gulluoglu, Mine G ^a   Esen, Tarik ^a   Uysal, Veli ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Ki 67; p53; Progression; Recurrence; Superficial urothelial cell carcinoma; Urinary bladder

Indexed keywords

ANTIBODY; KI 67 ANTIGEN; PARAFFIN; PROTEIN P53;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER TISSUE; CARCINOMA CELL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0036373060     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2002.01371.x     Document Type: Article

References (35)

1. Cancer statistics
2. p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer
3. Diseases of the urinary bladder, urethra, ureters and renal pelvis
4. Prognostic markers in bladder cancer: A contemporary review of the literature
5. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer
6. Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer
7. The prognostic value of p53 nuclear overexpression and MIB1 as a proliferative marker in transitional cell carcinoma of the bladder
8. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder
9. The application of a prognostic factor analysis for Ta-T1 bladder cancer in routine urological practice
10. p53, the cellular gatekeeper for growth and division
11. Overexpression and mutation of p53 in epithelial ovarian cancer
12. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression
13. Accumulation of nuclear p53 and tumor progression in bladder cancer
14. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67
15. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: Association with tumor progression
16. Histological typing of urinary bladder tumours
17. Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: Immunohistochemical analysis of radical cystectomy specimens
18. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer
19. p53 and c-jun expression in urinary bladder transitional cell carcinoma: Correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage
20. Overexpression of p53 protein and significance for recurrent progressive bladder tumours
21. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: Correlation with Ki-67 index
22. Invasion of the bladder by transitional cell carcinoma. Its relation to histologic grade and expression of p53, MIB 1, c-erb B-2, epidermal growth factor receptor, and bcl-2
23. The prevalence of bcl-2, p53 and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates
24. Overexpression of the p53 nuclear oncoprotein in transitional cell carcinoma of the bladder and its prognostic value
25. p53 in tumour pathology: Can we trust immunohistochemistry? -Revisited!
26. Alterations of tumor suppressor genes in bladder cancer
27. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder
28. Patterns of p53, erbB-2 and EGF-r expression in premalignant lesions of the urinary bladder
29. Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67
30. Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining
31. Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors
32. Comparison of five histopathologic methods to asses cellular proliferation in transitional cell carcinoma of the urinary bladder
33. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: Its potential clinical importance
34. p53 immunohistochemistry: A word of caution